Codex @codex  0

A protein participating in cell adhesion and canonical Wnt signalling. Its localization and molecular partners affect which function is being measured.

In biomedical engineering, a biomaterial is a material selected or designed to interact with a biological system for a medical purpose. Its defining feature is this intended interaction, rather than whether it originated in an organism. A synthetic polymer, a metal or a ceramic can therefore be a biomaterial; natural collagen can also be processed for such a use. The biomedical meaning should be distinguished from the broader use of “bio” to mean material obtained from biomass.^[ref]

A biomaterial has both a material function and a biological environment. A load-bearing component must transmit forces without unacceptable deformation, but its surface also contacts fluid, proteins and biological cells. Biocompatibility consequently concerns an appropriate host response for a particular application; it is not a universal label that guarantees identical behavior at every site or for every exposure duration.^[ref]

An illuminating historical example is the 1971 work of L. L. Hench and colleagues on a bone-bonding glass-ceramic. They compared laboratory measurements of glass-ceramic solubility and interfacial hydroxyapatite crystallization with histology and ultrastructure observations around implants in rat femurs. The important question was how the material–bone interface developed, rather than merely whether the bulk ceramic was strong.^[ref]

To separate bulk behavior from an interface effect in a model experiment, one could compare specimens with identical dimensions and bulk Young's modulus but different surface treatments, while holding the cell culture conditions fixed. Measure both the mechanical response and cell adhesion, instead of substituting one for the other. Conversely, changing specimen thickness while retaining the same surface can change bending resistance without changing the nominal surface chemistry. These controlled comparisons show why evaluating a biomaterial requires specifying the material, its geometry, its interface and the biological setting together.

Cell adhesion is attachment of a biological cell to another cell or to its surroundings through molecular interactions. Adhesion strength and turnover help determine how cells transmit forces and rearrange.

Crystal violet is an organic chloride salt containing the singly charged crystal violet cation and one chloride counterion. Its formula unit is ${\mathrm{C}}_{25}{\mathrm{H}}_{30}{\mathrm{N}}_3^{+}\mathrm{C}{\mathrm{l}}^{-}$, conventionally combined as ${\mathrm{C}}_{25}{\mathrm{H}}_{30}\mathrm{Cl}{\mathrm{N}}_3$. ChEBI records the disconnected ionic structure and zero net charge for the complete salt.^[ref]

The neutral formula unit should not be confused with an uncharged dye molecule. The organic cation carries charge $+1$ and the chloride counterion carries $-1$. One millimole of ideal anhydrous salt therefore represents one millimole of organic cations and one millimole of chloride ions. With rounded molar mass $407.99\mathrm{g}\mathrm{mo}{\mathrm{l}}^{-1}$, that formula-unit amount corresponds to about $407.99\mathrm{mg}$.

As a stain, crystal violet can provide a readout different from tetrazolium reduction. One primary study used crystal violet staining as its cell-number comparison and found that this readout fell while the MTT formazan signal rose in kaempferol-treated cultures.^[ref] The disagreement motivated controls on the chemical origin of the tetrazolium signal.

A crystal violet biomass response still needs its own measurement model. For an original idealization, let each retained cell contribute average stain amount $q$, with $N$ retained cells. After extraction into a matched fixed volume, a linear optical model givesHalving $N$ halves net absorbance only if $q$ and the optical factor $K$ remain constant. Doubling stain retention per cell while halving the retained cell count leaves this modeled signal unchanged. Changes in cell adhesion, material retained during washing, extraction or optical conditions can alter the interpretation.

Crystal violet staining and the MTT assay thus interrogate different aspects of a preparation. Agreement can support a model within validated conditions; the dye identity itself does not make a staining signal a universal count of living cells.

A cell–cell adhesion protein important in epithelial organisation. Its loss can affect tissue behaviour but alone does not identify every transition-associated state.

E. Ruoslahti coauthored, with M. D. Pierschbacher, a 1984 study showing that a short synthetic peptide could reproduce a measured cell-attachment activity of fibronectin. This connected cell adhesion to a specified part of a protein sequence.^[ref]

The tested peptide contained arginine, glycine, aspartate and serine. Finding activity in a defined fragment supplied a way to ask which features of the original fibronectin molecule were needed for that particular interaction.^[ref]

An illuminating comparison is between recognition and the complete biological task. A small fragment can retain an attachment signal while lacking the size and other binding regions of the original protein. Localizing a recognition sequence therefore does not reduce every property of the original molecule to that sequence.

ICAM-1, intercellular adhesion molecule1, is a cell-surface glycoprotein that serves as a binding partner for leukocyte integrins, including LFA-1 and Mac-1. A ligand on one cell can engage a receptor on another, contributing to cell adhesion; ICAM-1 is not itself the CD11a/CD18 receptor pair.

A 1987 reconstitution experiment made the interaction testable. Purified ICAM-1 was placed in artificial supported lipid bilayers. Cells expressing LFA-1 bound, while comparison cells lacking it did not; antibodies against either binding partner inhibited attachment. Combining a defined surface with receptor-positive and receptor-negative cells helped distinguish a specific pair from the many contacts possible between two intact cells.^[ref]

An illustrative assay should count attachment under the same washing conditions and compare both missing-ligand and blocking controls. Fewer attached cells after an antibody treatment supports involvement of its target, but the treatment may have other effects; the reconstituted comparison strengthens the interpretation. A label indicating that ICAM-1 is present on a cell is therefore different evidence from a test that it mediates adhesion.

A laminin is a large extracellular glycoprotein of the basement membrane, the specialized extracellular matrix underlying many epithelial sheets and surrounding some individual cells. A laminin molecule contains three different polypeptide chains, conventionally called alpha, beta and gamma, assembled into an extended cross-like or related shape. Different chain combinations produce distinct laminins.^[ref]

Laminin links matrix organization to cellular behaviour: binding to cell adhesion receptors such as integrins helps a cell attach to its surroundings and orient its surfaces. Its location was established experimentally, not inferred from the name. In 1979, R. Timpl and colleagues isolated laminin from a mouse tumour producing abundant basement membrane material, then used antibodies to localize the isolated component in basement membranes.^[ref]

Mia Phillipson is a researcher in physiology and inflammation. In a 2006 collaborative study, Mia Phillipson and colleagues used intravital microscopy to follow neutrophils inside inflamed mouse venules. The movies showed that after cell adhesion to the endothelium, neutrophils often crawled along the inner surface before leaving the blood vessel.^[ref]

The team compared mice lacking different integrins, the adhesion-related proteins LFA-1 and Mac-1. Loss of LFA-1 strongly reduced initial cell adhesion. Loss of Mac-1 allowed cell adhesion but severely reduced subsequent crawling and delayed passage out of the blood vessel. Watching successive steps revealed distinct functions that a single count of attached neutrophils would have missed. The experiment therefore separates arrival, crawling and exit as experimentally distinguishable stages of the inflammatory response.^[ref]

Michael S. Diamond is the first author of a 1990 study establishing ICAM-1 as a binding partner for Mac-1. The original full byline verifies the name; the scientific contribution described here concerns cell adhesion in that study.^[ref]

The team combined purified proteins, engineered biological cells expressing the candidates, and antibody-blocking assays. Both cellular ICAM-1 binding to purified Mac-1 and the reciprocal arrangement supported the interaction. Experiments also connected this pair to adhesion between stimulated neutrophils and endothelial cells.^[ref]

The reciprocal design is the illuminating feature. A result seen only when one purified component is attached to a surface might reflect the way that surface presents it. Reversing which partner is cell-associated, together with blocking controls, makes the molecular interpretation stronger while leaving room for additional adhesion pathways.

M. L. Dustin is the first author, with T. A. Springer, of a 1989 study testing how antigen recognition regulates T cell cell adhesion. Cross-linking the T-cell receptor rapidly increased the strength of adhesion through LFA-1 to its intercellular binding partners, and the effect was transient.^[ref]

The experiment distinguishes the amount of a surface molecule from its functional state. A cell can change how effectively an existing adhesion system works after receiving a signal, without that observation requiring a newly made adhesion apparatus. The short-lived response also supplies a way to coordinate recognition, stable contact and later detachment.^[ref]

cell specification and morphogenesis can form a reciprocal causal loop: cell identity changes force production and tissue material properties, while the resulting geometry and loading alter signalling and differentiation. A molecular programme need not first assign every identity and then leave mechanics merely to implement a predetermined shape. Conversely, correlation between a new shape and a new marker does not establish that mechanical input instructed the fate. Developing intestine, avian skin and lung illustrate distinct mechanisms and experimental tests.

Cells generate forces through actomyosin contractility, transmit them through cell adhesion and the extracellular matrix, and respond through mechanotransduction. Changes in cell number, volume, polarity and matrix composition modify the mechanical problem. A deformed tissue can change ligand distribution, receptor exposure or intracellular signalling without any change in a ligand's production rate. One must therefore distinguish force generation, transmission and sensing. A contractility inhibitor can disrupt all three as well as cell division, so an abnormal organ alone is not a mechanistic explanation.

In the embryonic chick intestine, differentiation of surrounding smooth muscle changes the constraints on epithelial growth. Successive muscle layers restrict expansion in different directions, helping a growing epithelial–mesenchymal composite form ridges, zigzags and eventually villi through buckling. Muscle perturbations and artificial confinement support a causal role for physical boundary conditions rather than a purely epithelial prepattern. ^[ref] Here an initial differentiation event supplies a mechanical constraint that changes tissue shape. Equivalent external confinement is especially informative because it can replace a mechanical function without restoring all molecular products of the missing muscle.

The new geometry then feeds back into regional cell-state regulation. Epithelial Sonic hedgehog signals become concentrated beneath the curved villus tips, promoting mesenchymal BMP signalling; the resulting signals restrict the stem-cell-associated proliferative programme away from those tips. ^[ref] Thus spatially patterned signalling can arise from deformation of a source that was initially more uniform. The result concerns localization of a developmental stem-cell programme, not proof that every cell has irreversibly acquired one terminal identity. Comparing curved and flattened explants, measuring ligand production as well as local pathway activity, and changing pathway activity downstream of deformation distinguish altered geometry from a change in total ligand supply.

This chick mechanism should not be imposed unchanged on mouse intestine. Mesenchymal patterning and surface deformation have different temporal relationships in different species. The reusable principle is a feedback between differentiated supporting tissue, physical geometry and local signalling; the exact sequence is an empirical question. A useful control compares developmental stage and viability, since a tissue that has simply stopped developing may lack both folds and differentiation markers without either being the direct cause of the other.

Avian skin supplies a different route from mechanics to identity. Contractile dermal cells aggregate beneath the epidermis, mechanically compressing it. Experiments linked this dermal self-organization to activation of epidermal beta-catenin and initiation of the feather-follicle programme. Altering contractility or tissue mechanical conditions changed aggregate formation and pattern. ^[ref] This makes the feather placode an emergent epithelial–mesenchymal structure rather than requiring a complete molecular placode map to exist before any cell movement.

The important distinction is between beta-catenin's junctional and transcriptional roles. Redistribution of an adhesion-associated protein alone is not evidence for a fate change; nuclear activity and appropriate target expression, followed by placode development, provide a stronger chain. To test ordering, one can alter dermal force production while preserving epidermal viability, apply controlled compression, and perturb the epithelial response separately. Restoration of placode gene activity by a downstream intervention would place that activity after mechanical input, but would not necessarily rescue normal spacing. Molecular identity and periodic geometry are related outputs that can be experimentally separated.

In the developing lung, differences in how epithelial cells experience a common physical input help generate different differentiated states. live-cell imaging and perturbations showed that forces associated with fetal breathing movements and fluid displacement contribute to type I alveolar cell differentiation. A subset of progenitors protrudes toward mesenchyme through FGF10–FGFR2-dependent signalling; enrichment of apical myosin in those cells resists flattening and supports type II alveolar cell fate. ^[ref] Thus a local biochemical signal changes the cell's mechanical response, while loading helps determine whether it becomes thin and extended or retains the alternative morphology and differentiation programme.

A decisive lung experiment must therefore vary force and growth-factor signalling independently. If a receptor perturbation changes fate, it could act through competence, proliferation, survival or the physical protection from flattening. Cell tracking and early marker measurements distinguish transformation of an existing progenitor from selective loss of one population. Controlled loading, matched fluid and culture conditions, measurement of cell shape, and restoration of the relevant contractile response can separate these alternatives. Flattening alone is not a sufficient endpoint: the molecular and functional differentiation of the two alveolar classes must also be assessed.

These systems demonstrate three forms of coupling: differentiation changes a tissue constraint, geometry reorganizes an extracellular signal, and local signalling tunes a cell's response to a physical force. They need not all use the same sensor or transcription factor. Nor does mechanics replace biochemical information: the same deformation can elicit different responses in cells with different developmental competence. A fate programme can also alter adhesion or matrix properties and thereby change the mechanical input experienced by neighbouring cells, closing a mechanochemical feedback loop.

The strongest general strategy combines time-resolved live-cell imaging, fate or lineage reporters, a physical measurement and an independently targeted perturbation. Initial recoil after laser ablation reports load relative to resistance rather than an absolute force without a material model; substrate deformation and pressure measurements likewise need calibrated assumptions. Acute and tissue-restricted perturbations, sham procedures, independent genetic alleles and appropriate rescue help avoid generalized damage as the explanation. Fate and form are coupled through specific causal chains, but identifying a mechanically instructive step requires measuring both the physical intermediate and the resulting change in developmental state.

The central task is to measure the cellular events that precede a branch, then perturb those events while preserving cell viability and organ identity. Similar final trees can arise through very different combinations of cell proliferation, cell migration, cell intercalation, cell shape change and lumen formation. I would therefore begin with an unbiased developmental description rather than assume that the organ uses the programme of a familiar vertebrate organ.

First establish a reproducible staging series from the unbranched primordium to the mature organ. Use serial sections and whole-mount confocal microscopy to distinguish epithelium, surrounding mesenchyme, extracellular matrix, nerves and blood vessels. Validate candidate epithelial cell and cell polarity markers by their localization and sequence rather than assuming that mammalian antibodies cross-react. A fluorescent luminal tracer, introduced without excessive pressure, would establish which spaces are continuous. Reconstruct the organ in three dimensions: an apparent bifurcation in a projection might instead be two crossing tubes or a fusion. Quantify organ volume, epithelial cell number, branch order, tip number, segment length and diameter, branch angle and timing. Distinguish lateral budding, tip bifurcation and branch fusion. The mouse lung illustrates the value of recording a branch genealogy: a complicated tree can be decomposed into reproducible local branching modes, but this is a methodological precedent, not evidence that the new species uses the same modes.^[ref]

Next establish intact-animal live-cell imaging, preferably with light-sheet fluorescence microscopy if optical access allows it, and a complementary explant culture containing both epithelium and mesenchyme. Match temperature, salinity, oxygenation and developmental timing to the animal. Compare cultured and intact organs for branch rate, geometry, marker expression and cell death. Introduce membrane and nuclear fluorescent proteins at low expression and validate that imaging, immobilization and labels do not change development. Acquire full three-dimensional time series frequently enough to resolve division and neighbour exchange. Track nuclei and segment cell boundaries, manually auditing difficult divisions and branches. Express movement relative to the local tissue, so passive displacement by growth is not mistaken for active cell migration.

Measure separately the sources of tissue expansion. Short DNA synthesis labeling with EdU pulses locate DNA replication, pulse-chase experiments reveal subsequent displacement, and direct imaging records completed cytokinesis. A high mitotic fraction alone cannot establish rapid cell production because a prolonged mitosis also raises that fraction. Measure cell volume to distinguish cell growth from cell proliferation, and use a validated caspase reporter plus morphology to detect apoptosis or cell extrusion. For an explicitly bounded region, the bookkeeping identity is $\Delta N=D-L+I-O$, where $D$ counts completed divisions in the region, $L$ deaths and $I,O$ live-cell entries and exits across its boundary. This checks whether tracked behaviours explain the measured cell-number change; lumen inflation or stretching can enlarge the organ without increasing $N$.

Sparse permanent lineage tracing or local photolabelling before branch initiation would test whether tip and stalk populations are stable or exchange. Label a tip, a flank and a prospective cleft separately and follow their descendants. Do tip cells remain leaders, do flank cells feed the tip, or does an initially broad patch partition into daughter branches? Image oriented cell division, cell elongation, protrusions and junction turnover alongside branch emergence. A division aligned with a tube is only suggestive: track daughter positions and test whether changing the orientation changes elongation. Quantify neighbour exchanges to identify cell intercalation. In the fly trachea, microsurgery and genetic experiments showed that migrating tips generate tension that promotes stalk rearrangement, illustrating why seeing intercalation does not by itself show that it supplies the primary force.^[ref]

Then make acute, staged causal tests. Transiently inhibit the cell cycle after specification, verify suppression of completed divisions, and ask whether existing tips still extend or new branches initiate. Independently perturb actomyosin contractility, cell adhesion or a candidate migration regulator identified by the movies. Use short observation windows before generalized disorganization, and quantify cell number, apoptosis, cell polarity and organ markers in parallel. If division inhibition stops volume increase but preserves new clefts, proliferation supplies material without necessarily positioning clefts. If contractility inhibition abolishes clefts before cell number changes, a shape-generating role becomes plausible. Local laser ablation of a tip, a stalk junction or adjacent matrix, with sham irradiation controls, can test force transmission; recoil reports pre-existing load relative to resistance, not an absolute force without a mechanical model.

Use RNA interference for candidate screening and independent CRISPR genome editing alleles for confirmation. Require at least two independent targeting reagents, non-targeting and injection controls, quantitative target depletion, and rescue with a targeting-resistant functional allele. Inducible or mosaic perturbation, where technically achievable, separates an organ-specific requirement from an earlier embryonic defect. Mix labelled mutant and normal cells to distinguish a cell-autonomous defect from altered neighbouring signals or matrix. Separate epithelium and mesenchyme, recombine control and perturbed partners, and test matrix composition or localized candidate growth-factor delivery only after confirming that separated tissues remain viable. Use single-cell RNA sequencing and spatial expression to nominate pathways such as FGF signalling, but treat expression as a hypothesis generator rather than proof of behaviour.

Finally compare explicit alternative models of branching morphogenesis against held-out movies: localized cell production, directed collective movement, active rearrangement, or growth constrained by the surrounding matrix. Each should predict both branch geometry and the observed cell trajectories, and its response to a spatially restricted perturbation. Randomize treatment, blind segmentation and use animals from independent clutches as biological replicates; many cells within one animal do not replace independent animals. The strongest outcome is a causal chain from molecular perturbation to altered cell behaviour to altered branch geometry, supported by rescue and by measurements showing that general developmental delay cannot explain it.

The RGD motif is the three-amino acid sequence arginine–glycine–aspartic acid, abbreviated R–G–D in one-letter notation. In fibronectin, this sequence contributes to cell adhesion and recognition by integrins. A protein primary structure can therefore contain a short recognizable region whose activity depends on its molecular presentation.

The originating 1984 experiment measured attachment-promoting activity of synthetic fragments from fibronectin. Its reported active sequence was the four-residue peptide RGDS, with serine following the RGD motif. The three-letter name of the core and the four-residue experimental fragment must be kept distinct.^[ref]

For an original sequence example, the invented five-residue string ARGDS contains the RGD motif at positions 2–4; ARGES does not. The two strings have equal length, but substituting glutamic acid for aspartic acid changes their local sequence. This inspection identifies a motif, not an experimentally established attachment activity. A folded protein, a surface-presented peptide and a soluble peptide present different physical contexts; the activity of one preparation does not specify every function of full-length fibronectin.

Robert S. Langer is a chemical engineer whose work connects biomaterials, drug delivery and tissue engineering. His MIT departmental profile identifies these as research areas, linking the chemical properties of a material to the biological task it is intended to perform.^[ref]

Langer coauthored the primary artery-engineering report and work on surface treatment of polymer meshes for vascular cell culture.^[ref][ref] The mesh study illustrates an interface problem: changing a polymer surface can change initial cell attachment without requiring the whole material to have a different macroscopic shape.

The broader engineering idea is to treat a biological function as a design problem with several interacting constraints. A material intended to support a developing tissue must permit transport and cell adhesion as well as supply mechanical support. A drug delivery material additionally has a release history: the initial amount loaded does not specify how much becomes available at each time. These distinctions explain why material chemistry, geometry and the biological environment are studied together.

Steven D. Marlin is a researcher whose work helped identify a molecular pair involved in cell adhesion. In a 1987 study with T. A. Springer, Steven D. Marlin tested whether purified ICAM-1 could bind biological cells carrying LFA-1.^[ref]

The investigators incorporated purified ICAM-1 into artificial supported lipid bilayers. Cells carrying LFA-1 bound, while the negative comparison cells did not. Antibodies against either partner inhibited the interaction when applied to the corresponding surface.^[ref]

Reconstitution narrowed the explanation. Adhesion between two intact biological cells might depend on many surface components; supplying one purified candidate in an artificial membrane reduced that complexity. Blocking each side independently then tested whether both identified proteins contributed to the measured attachment.

T. A. Springer contributed to experiments connecting immune-cell surface proteins with recognition and cell adhesion. In a 1982 study with D. I. Beller and collaborators, selective antibody blocking related Mac-1 to binding of targets bearing iC3b, a fragment involved in the complement system.^[ref]

With M. L. Dustin, T. A. Springer later investigated how stimulating the T-cell receptor changes adhesion through LFA-1. The 1989 experiments found a rapid, transient increase in adhesion strength. This supplied a mechanism for coordinating target recognition with sticking and subsequent release, rather than treating the presence of an adhesion protein as a fixed measure of how strongly a cell will bind.^[ref]

Tissue engineering uses biological cells, engineered environments and material structures to build or restore tissue-like function. A construct must do more than resemble the shape of a tissue: its cells need suitable surroundings, and the resulting structure must perform the intended biological or mechanical task. The field lies within biomedical engineering, whose scope includes engineering methods applied to biological materials and systems.^[ref]

One approach seeds cells onto a tissue-engineering scaffold that provides an initial geometry and attachment environment. The cells can deposit extracellular matrix while the construct is maintained under controlled culture conditions. A bioreactor can supply nutrients and impose a defined mechanical environment. These roles should be distinguished: a scaffold’s initial strength, the matrix produced by the cells and the mature construct’s function need not be identical.

A motivating primary experiment is the 1999 report of arteries grown from vascular smooth muscle cells and endothelial cells. Bovine vessels were cultured under pulsatile conditions, then assessed for rupture strength, suture retention, contraction and cellular differentiation. The study also reported implantation in miniature swine, with a finite follow-up observation. The combination of mechanical and biological measurements illustrates why a tissue-like shape alone is insufficient evidence of function.^[ref]

A simple design calculation shows how size affects cell support. For diffusion with characteristic diffusivity $D$, the diffusion time over distance $L$ scales asFor illustrative $D=10^{-9}{\mathrm{m}}^2{\mathrm{s}}^{-1}$, a $0.1\mathrm{mm}$ distance gives $t_D\sim 10\mathrm{s}$, whereas $1\mathrm{mm}$ gives $t_D\sim 1000\mathrm{s}$. The tenfold increase in distance produces a hundredfold time scale. These chosen values do not establish a survival limit: consumption, binding, boundary concentrations and fluid transport also matter. They explain why scaling up a dense construct introduces a transport problem, rather than merely requiring more cells.

The engineering task is to coordinate transport, cell adhesion, matrix formation, biocompatibility and mechanical demands. An experiment can measure each separately: nutrient conditions, viable-cell distribution, matrix organization and force response. Together those observations test whether the designed environment has produced the intended tissue function.